TRAT1 and metabolic disease: Studies have shown that specific TRIM proteins are key regulators in metabolic disorders, including type 2 diabetes, obesity, non-alcoholic fatty liver disease, and atherosclerosis (Xu et al, 2008; Yang et al, 2016).